Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SYCOmed is a German diagnostics and medical technology company focused on hemostasis testing, coagulation analyzers, diagnostic reagents, and point-of-care laboratory systems. The company develops, manufactures, markets, and services blood coagulation instruments including ball coagulometers, optical coagulation devices, thromboelastometry systems, handheld hemoglobin meters, and fluorescence-based immunoassay analyzers. Its product offering also includes hemostasis reagents, consumables, accessories, and maintenance and refurbishing services for legacy AMELUNG hook and ball coagulometers. Based in Lemgo, Germany, SYCOmed positions itself as a family-run specialist serving laboratories, clinics, universities, healthcare centers, and physicians worldwide. The business appears to be a commercial-stage diagnostics supplier rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SYCOmed.